Lindsay Allen
Vice President, Investor Relations and Communications
Replay available
Amylyx Pharmaceuticals, Inc. (AMLX) Q3 2025 Earnings Call
Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) Q3 2025 earnings conference call, held 2025-11-06. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Justin Klee
Co-Chief Executive Officer
Dr. Camille Bedrosian
Chief Medical Officer
Jim Fradies
Chief Financial Officer
Josh Cohen
Co-Chief Executive Officer
Seamus Fernandez
Analyst, Guggenheim
Joseph Thorne
Analyst, TD Cowan
Mark Goodman
Analyst, Leerink Partners
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Amylyx Pharmaceuticals, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:04.155 Good morning. My name is Carly, and I will be your conference operator today. 00:00:04.155 -- 00:00:09.260 At this time, I would like to welcome everyone to the Amelix Pharmaceuticals Third Quarter 00:00:09.260 -- 00:00:14.405 Earnings Conference Call. All participants will be in listen-only mode. 00:00:14.405 -- 00:00:19.250 After today's presentation, there will be an opportunity to ask questions. 00:00:19.250 -- 00:00:24.154 To ask a question, please press star 1 on your telephone keypad. 00:00:24.154 -- 00:00:27.740 To withdraw your question, press star 1 again. 00:00:27.740 -- 00:00:31.547 Please limit your questions to one with one follow-up. 00:00:31.547 -- 00:00:35.295 If you have additional questions, you may rejoin the queue. 00:00:35.295 -- 00:00:40.425 Please be advised that this call is being recorded at the company's request. 00:00:40.425 -- 00:00:45.956 I would now like to turn the call over to Lindsay Allen, Vice President, Investor Relations 00:00:45.956 -- 00:00:49.739 and Communications. Please proceed. 00:00:50.369 -- 00:00:55.556 Good morning, and thank you all for joining us today to discuss our third quarter 2025 00:00:55.556 -- 00:01:01.063 financial results and business updates. With me on the call today are Josh Cohen 00:01:01.063 -- 00:01:03.887 and Justin Klee, our co-CEOs, 00:01:03.887 -- 00:01:09.214 Dr. Camille Bedrosian, our chief medical officer, and Jim Fradies, our chief financial 00:01:09.214 -- 00:01:14.280 officer. Before we begin, I would like to remind everyone that any statements 00:01:14.280 -- 00:01:19.528 we make or information presented on this call that are not historical facts are forward-looking 00:01:19.528 -- 00:01:24.616 statements that are based on our current beliefs, plans, and ...